Company news
MediPharm Labs Corp. news in 2023
MediPharm Labs Corp.'s news releases, calls and decks from 2023, newest first.
MediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program
December 22, 2023
MediPharm Labs Sets Date to Report Third Quarter 2023 Financial Results
November 8, 2023
MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to Cash
October 25, 2023
MediPharm Labs Settles an Outstanding Claim for $9M
October 2, 2023
MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis Market
September 27, 2023
MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty Agreement
September 20, 2023
MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 million
September 5, 2023
MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia Patients
August 31, 2023
MediPharm Labs Reports Second Quarter Results with Doubling of Revenue and Record Margin Growth
August 14, 2023
MediPharm Labs Sets Date to Report Second Quarter 2023 Financial Results
August 10, 2023
MediPharm Labs Makes First Delivery of Cannabis Clinical Trial Material to US Research Partner and Provides Update on US FDA Status
August 1, 2023
MediPharm Labs Announces Change of Auditor
June 22, 2023
MediPharm Labs Reports First Quarter Results with Growth in Sales, Margin and EBITDA
May 15, 2023
MediPharm Labs Sets Date to Report First Quarter 2023 Financial Results
May 10, 2023
MediPharm Labs Provides Update on VIVO Integration and Board Appointee
April 13, 2023
MediPharm Labs Corp. Completes Acquisition of VIVO Cannabis Inc. and Confirms Final Ownership Ratio
April 3, 2023
MediPharm Labs Reports Fourth Quarter and Full Year 2022 Results
March 31, 2023
MediPharm Labs Sets Date to Report Fourth Quarter and Full Year 2022 Financial Results
March 28, 2023
MediPharm Labs Corp. Announces Voting Results From Special Meeting of Shareholders
March 21, 2023
MediPharm Labs Provides Update on Clinical Trial Progress Including FDA Approval of Partner Study
March 1, 2023
MediPharm Labs Corp. Announces Mailing and Filing of Joint Circular for Special Meeting of Shareholders to approve Arrangement with VIVO Cannabis Inc.
February 21, 2023